Insecticides (India) FY26 Revenue Up; Profit Dips Slightly, ESPS Scheme Approved

AGRICULTURE
Whalesbook Corporate News Logo
AuthorVihaan Mehta|Published at:
Insecticides (India) FY26 Revenue Up; Profit Dips Slightly, ESPS Scheme Approved
Overview

Insecticides (India) Limited reported its audited FY26 results. Revenue grew to ₹2,144 crore, but net profit saw a marginal dip to ₹135.82 crore. The company also approved an employee stock scheme and made management changes.

Instant Stock Alerts on WhatsApp

Used by 10,000+ active investors

1

Add Stocks

Select the stocks you want to track in real time.

2

Get Alerts on WhatsApp

Receive instant updates directly to WhatsApp.

  • Quarterly Results
  • Concall Announcements
  • New Orders & Big Deals
  • Capex Announcements
  • Bulk Deals
  • And much more

Insecticides (India) Limited FY26 Results and Key Announcements

Revenue from operations: ₹2,144.14 crore
Profit for the year: ₹135.82 crore

Reader Takeaway: Revenue growth driven by expansion; profit dip and management changes need monitoring.

What just happened

Insecticides (India) Limited has announced its audited financial results for the fourth quarter and the full financial year ended March 31, 2026. The company reported a revenue of ₹2,144.14 crore for FY26, an increase from ₹2,002.26 crore in FY25. However, the standalone net profit for FY26 was ₹135.82 crore, a slight decrease from ₹139.77 crore in the previous year. The company also saw changes in its management structure and approved an Employee Stock Purchase Scheme (ESPS) 2026.

Why this matters

The results indicate steady revenue growth, a positive sign for the company's market reach. However, the marginal decline in net profit and basic EPS warrants attention from investors. The approval of the ESPS scheme and management changes suggest forward-looking strategies for employee retention and leadership succession.

The backstory

Insecticides (India) Limited is a significant player in the agrochemical sector. The company has been focusing on expanding its product portfolio and market presence. The recent announcement also includes the dissolution of its wholly-owned foreign subsidiary, IIL Overseas DMCC, which had ceased operations earlier.

What changes now

With the new financial year commencing, investors will track the execution of the ESPS 2026 scheme and its impact on employee motivation and shareholding patterns. Management changes, including the appointment of Mr. Sanskar Aggarwal as Whole Time Director, will be key to the company's future strategic direction. The appointment of a new internal auditor for five years also brings a fresh perspective to financial oversight.

Risks to watch

The slight decrease in profitability despite revenue growth is a key risk to monitor. Investors should also watch for any impact from the dissolution of the foreign subsidiary. The agrochemical sector is also subject to weather patterns and government policies, which can affect performance.

Peer comparison

While specific peer comparison data is not provided in the filing, the Indian agrochemical industry is competitive. Companies often focus on R&D, product launches, and distribution networks. Insecticides (India) Limited's performance should be viewed against the broader industry trends and its peers' financial outcomes.

Context metrics (time-bound)

  • Revenue FY26: ₹2,144.14 crore (vs. ₹2,002.26 crore in FY25)
  • Profit FY26: ₹135.82 crore (vs. ₹139.77 crore in FY25)
  • Basic EPS FY26: ₹46.68 (vs. ₹47.61 in FY25)
  • ESPS 2026: Up to 2,00,000 equity shares approved.
  • IIL Overseas DMCC Dissolution: Effective September 19, 2025.

What to track next

Investors should closely monitor the company's performance in the upcoming quarters, particularly the profitability margins. The successful implementation of the ESPS scheme and any future strategic initiatives by the new management will also be crucial indicators.

Get stock alerts instantly on WhatsApp

Quarterly results, bulk deals, concall updates and major announcements delivered in real time.

Disclaimer:This content is for educational and informational purposes only and does not constitute investment, financial, or trading advice, nor a recommendation to buy or sell any securities. Readers should consult a SEBI-registered advisor before making investment decisions, as markets involve risk and past performance does not guarantee future results. The publisher and authors accept no liability for any losses. Some content may be AI-generated and may contain errors; accuracy and completeness are not guaranteed. Views expressed do not reflect the publication’s editorial stance.